Non-alcoholic Fatty Liver Disease (MASLD) Clinical Trial
Official title:
Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey
The purpose of this study is to better understand the main barriers to earlier diagnosis and better management of MASLD/MASH patients and to understand the key barriers to adoption of guidelines. This study is a cross-sectional design, conducted across 5 countries in Europe- France, Germany, Spain, United Kingdom (UK), Italy. Study participants, Hepatologists and other metabolically focused healthcare providers (HCPs), will be recruited to complete a 15 minute self-administered online survey.
n/a